(NASDAQ: LIN) Linde's forecast annual revenue growth rate of 4.43% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.15%.
Linde's revenue in 2025 is $33,504,000,000.On average, 26 Wall Street analysts forecast LIN's revenue for 2025 to be $15,978,058,486,740, with the lowest LIN revenue forecast at $15,244,948,666,640, and the highest LIN revenue forecast at $17,109,008,795,200. On average, 26 Wall Street analysts forecast LIN's revenue for 2026 to be $16,863,860,606,950, with the lowest LIN revenue forecast at $15,831,436,522,720, and the highest LIN revenue forecast at $18,069,989,693,140.
In 2027, LIN is forecast to generate $17,836,515,228,140 in revenue, with the lowest revenue forecast at $16,777,008,105,970 and the highest revenue forecast at $19,341,491,629,530.